Literature DB >> 12529334

Phosphorylation of p16INK4A correlates with Cdk4 association.

Jay Gump1, David Stokoe, Frank McCormick.   

Abstract

Progression through the eukaryotic cell cycle is driven by the activity of cyclin-dependent kinases. The cyclin D-dependent kinase Cdk4 promotes progression through the G(1) phase of the cell cycle and is deregulated in many human tumors. The tumor suppressor protein p16(INK4A) (p16) forms a complex with Cdk4 and inhibits kinase activity. Here we report that p16 is phosphorylated, and the phosphorylated form of p16 is preferentially associated with Cdk4 in normal human fibroblasts. We mapped phosphorylation sites on exogenously overexpressed p16 to serines 7, 8, 140, and 152 and found that endogenous p16 associated with Cdk4 is phosphorylated at serine 152. All mapped phosphorylation sites lie outside of the conserved kinase-binding domain of p16 but in regions of the protein affected by mutations in familial and sporadic cancer. Our results suggest a novel regulation of p16 activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529334     DOI: 10.1074/jbc.C200622200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.

Authors:  Junan Li; Ming Jye Poi; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2011-06-06       Impact factor: 3.162

2.  Effect of phosphorylation and methylation on the function of the p16INK4a protein in non-small cell lung cancer A549 cells.

Authors:  Wen-Long Ma; Lin Wang; Ling-Xia Liu; Xiu-Li Wang
Journal:  Oncol Lett       Date:  2015-08-17       Impact factor: 2.967

3.  IKKbeta specifically binds to P16 and phosphorylates Ser8 of P16.

Authors:  Yi Guo; Chunhua Yuan; Christopher M Weghorst; Junan Li
Journal:  Biochem Biophys Res Commun       Date:  2010-02-10       Impact factor: 3.575

Review 4.  Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma.

Authors:  Rebecca A Sager; Sarah J Backe; Elham Ahanin; Garrett Smith; Imad Nsouli; Mark R Woodford; Gennady Bratslavsky; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Nat Rev Urol       Date:  2022-03-09       Impact factor: 16.430

5.  Cell cycle-dependent phosphorylation of human CDC5 regulates RNA processing.

Authors:  Remo Gräub; Hope Lancero; Anissa Pedersen; Meihua Chu; Krishnan Padmanabhan; Xiao-Qin Xu; Paul Spitz; Robert Chalkley; Alma L Burlingame; David Stokoe; Harold S Bernstein
Journal:  Cell Cycle       Date:  2008-06-25       Impact factor: 4.534

6.  Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma.

Authors:  Yue Liu; Shang-Tao Wan; Ping Zhang; Wen-Xin Zhang; Jian-Ling Zheng; Jian-Xian Lin; Yong-Ping Li
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

7.  Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions.

Authors:  David A Drew; Thomas Devers; Nicole Horelik; Shi Yang; Michael O'Brien; Rong Wu; Daniel W Rosenberg
Journal:  Proteomics       Date:  2013-04-04       Impact factor: 3.984

8.  Regulation of CDK4.

Authors:  Laurence Bockstaele; Katia Coulonval; Hugues Kooken; Sabine Paternot; Pierre P Roger
Journal:  Cell Div       Date:  2006-11-08       Impact factor: 5.130

9.  The interplay between p16 serine phosphorylation and arginine methylation determines its function in modulating cellular apoptosis and senescence.

Authors:  Yang Lu; Wenlong Ma; Zhongwei Li; Jun Lu; Xiuli Wang
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

10.  p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells.

Authors:  Kimberly M McDermott; Jianmin Zhang; Charles R Holst; B Krystyna Kozakiewicz; Veena Singla; Thea D Tlsty
Journal:  PLoS Biol       Date:  2006-02-14       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.